review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0008-6363(99)00163-7 |
P698 | PubMed publication ID | 10690332 |
P2093 | author name string | Balligand JL | |
P433 | issue | 3 | |
P304 | page(s) | 607-620 | |
P577 | publication date | 1999-08-01 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Regulation of cardiac beta-adrenergic response by nitric oxide | |
P478 | volume | 43 |
Q38250438 | A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. |
Q38162217 | Adrenoreceptors and nitric oxide in the cardiovascular system |
Q44517359 | Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice |
Q91971280 | Angiotensin peptide synthesis and cyclic nucleotide modulation in sympathetic stellate ganglia |
Q36445252 | Beta 2-adrenergic receptor signaling acts via NO release to mediate ACh-induced activation of ATP-sensitive K+ current in cat atrial myocytes |
Q34106467 | Beta3-adrenoceptors in the cardiovascular system |
Q36415452 | Cardiac and vascular changes in cirrhosis: pathogenic mechanisms |
Q35035923 | Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity |
Q51171672 | Cardiac response to hemodialysis with different cardiovascular tolerance: heart rate variability and QT interval analysis. |
Q35546217 | Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase |
Q36188431 | Cytokines and cardiovascular disease |
Q46430408 | Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice |
Q43826659 | Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy |
Q44009034 | Effect of SIN-1 in rat ventricular myocytes: interference with beta-adrenergic stimulation |
Q51753029 | Exercise training improves myocardial tolerance to ischemia in male but not in female rats. |
Q28361071 | Guanosine 3': 5'-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats |
Q35045042 | Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes |
Q42506833 | Inhibition of nitric oxide synthase enhances contractile response of ventricular myocytes from streptozotocin-diabetic rats |
Q43988589 | Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha |
Q38862807 | Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation |
Q35037549 | Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. |
Q35045486 | Muscarinic regulation of cardiac ion channels |
Q90482425 | Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches |
Q33377761 | Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism |
Q35213988 | Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? |
Q28348784 | Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro |
Q79855253 | Nitroxyl increases force development in rat cardiac muscle |
Q35559033 | Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy |
Q37939132 | Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze |
Q34983537 | Positive inotropic and lusitropic effects of HNO/NO − in failing hearts: Independence from β-adrenergic signaling |
Q42451821 | Postanoxic functional recovery of the developing heart is slightly altered by endogenous or exogenous nitric oxide |
Q39070066 | Pro-inflammatory cytokines mediate GPCR dysfunction |
Q36474121 | Reactive oxygen species and autonomic regulation of cardiac excitability |
Q24805251 | Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T |
Q36887547 | Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface |
Q37376499 | Targeting cardiac sympatho-vagal imbalance using gene transfer of nitric oxide synthase |
Q35364575 | The cardiac response to exercise in cirrhosis |
Q36600711 | The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function |
Q42526635 | The expression pattern of nitric oxide-sensitive guanylyl cyclase in the rat heart changes during postnatal development |
Q47350159 | Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy |
Q42498817 | Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve |
Q34431362 | Vagal control of myocardial contractility in humans |
Q35047285 | Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide |
Search more.